West Penn Allegheny Clinical Trial Tests New Barrett’s Esophagus Treatment
C2T-admin 2018-05-30T19:48:05+00:00West Penn Allegheny Health System researchers are investigating whether a new ablation technology can provide safer and more effective treatment for patients with Barrett’s Esophagus, a condition associated with gastroesophageal reflux disease (GERD) that can progress to esophageal cancer if left untreated.